William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 4,180 shares at $5.98 ($25K) on 2022-01-27, disclosed to the SEC on 2022-01-28.
Open-market purchase of $25k VIRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VIRI | BUY | 2022-05-18 | $59K | — | Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |